𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SOD2: A new type of tumor-suppressor gene?

✍ Scribed by A. Bravard; L. Sabatier; F. Hoffschir; M. Ricoul; C. Luccioni; B. Dutrillaux

Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
736 KB
Volume
51
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The activity of superoxide dismutases (SOD) I and 2 was analysed in correlation with mRNA and chromosome content in 6 SV40‐transformed (TF) and in non‐transformed (NF) human fibroblast cell lines. Total SOD activity was fairly constant, whereas the ratio SOD2/SOD I was much lower in TF than in NF. The decrease in SOD2 activity was correlated with a low mRNA content, and with the presence of various chromosomal rearrangements leading to deletions of the long arm of chromosome 6 where the gene is mapped. In contrast, chromosome 21, carrying the gene for SODI, was not found to be deficient and the SODI activity was high. This shows that in TF, the activity of SOD2 is largely determined by gene dosage. It has been proposed that SOD activity could be inversely correlated with cell proliferation, and that SOD2 activity, in particular, was related to cell differentiation. Thus, there is a cascade of events occurring in cell transformation, involving gene deregulation, chromosome (gene) deletion, low mRNA and protein content, low enzyme activity, and acquisition of growth advantage which makes the SOD2 gene a possible new type of tumor‐suppressor gene.

πŸ“œ SIMILAR VOLUMES

Characterization of C4-2 as a tumor-supp
Characterization of C4-2 as a tumor-suppressor gene in human brain tumors
✍ Sehgal, Anil; Keener, Cassie; Boynton, Alton L.; Young, Ronald F.; Vermeulen, Sa πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 3 views

Background: Brain tumors claimed the lives of 13,300 people in 1995. Our objective was to isolate and characterize unique tumor-suppressor genes from human brain tumors derived from patients in the United States. Methods: Differential display-polymerase chain reaction was used to isolate tumor suppr

E-cadherin as a tumor (invasion) suppres
E-cadherin as a tumor (invasion) suppressor gene
✍ Walter Birchmeier πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 370 KB πŸ‘ 1 views

Diffuse-type gastric carcinomas show diminished cell-cell adhesion. A recent paper(') reports that 50% of these carcinomas contain mutations in the Ecadherin gene, resulting in the destruction of the calcium-binding sites of Ecadherin, and providing strong in vivo evidence that alterations in E-cadh

Mutations of p53 tumor-suppressor gene i
Mutations of p53 tumor-suppressor gene in angiosarcoma
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 50 KB πŸ‘ 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

The paradox of E2F1: Oncogene and tumor
The paradox of E2F1: Oncogene and tumor suppressor gene
✍ David G. Johnson πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

Cancer cells often contain mutations that lead to the loss of retinoblastoma tumor suppressor (Rb) function and the activation of E2F-dependent transcription. As a result, proliferation is deregulated, and sensitivity to apoptotic stimuli is increased. In cell culture studies, the transcription fact